Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. SYNA
2. ON
3. SPY
4. LFTO
5. QNT
6. MU
7. ACAD
8. AAPL
9. SPCX
10. NKE

Go back to Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences
(NASDAQ: KZR) Delayed: 7.29 --0 (-0%)
Previous Close $7.29    52 Week High $ 
Open $7.29    52 Week Low $ 
Day High $7.29    P/E N/A 
Day Low $7.29    EPS $ 
Volume 467